NCT06039449Phase 3Completed

A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2

Study sponsor: Invivyd, Inc. · IVVD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2024-11-19Actual
Enrollment · participants790Actual
Source updated2024-12-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview